Alyeska Investment Group »

Aeon Biopharma shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $576k 80k 7.20

More positions owned by Alyeska Investment Group

Oracle Corporation (ORCL)
Alphabet Cap Stk Cl A (GOOGL)
Twilio Cl A Call Option (TWLO)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Take-Two Interactive Software (TTWO)
Wal-Mart Stores (WMT)
Broadcom (AVGO)
Astrazeneca Sponsored Adr (AZN)
Adobe Systems Incorporated (ADBE)
Burlington Stores (BURL)
3M Company (MMM)
Lauder Estee Cos Cl A (EL)
Dollar General (DG)
Amazon (AMZN)
Dell Technologies CL C (DELL)

View all positions for Alyeska Investment Group

Top funds holding Aeon Biopharma

Atalaya Capital Management
Polar Securities
Vanguard Group
Ikarian Capital
BlackRock
Geode Capital Management
Goldman Sachs Group
BBK Capital Partners
Qube Research & Technologies
Millennium Management
Boothbay Fund Management
Northern Trust
Jane Street
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Aeon Biopharma